Mesoblast Ltd Files 6-K on Unquoted Equity Securities

Ticker: MEOBF · Form: 6-K · Filed: Dec 18, 2025 · CIK: 1345099

Mesoblast LTD 6-K Filing Summary
FieldDetail
CompanyMesoblast LTD (MEOBF)
Form Type6-K
Filed DateDec 18, 2025
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: equity-issuance, disclosure, foreign-private-issuer

Related Tickers: MESO

TL;DR

MESO filed a 6-K about unquoted equity securities being issued.

AI Summary

On December 17, 2025, Mesoblast Limited filed a Form 6-K with the SEC, reporting a new issue announcement to the Australian Securities Exchange. This announcement, an Appendix 3G, details the conversion or payment up of unquoted equity securities.

Why It Matters

This filing indicates potential changes in Mesoblast's equity structure, which could impact share count and ownership for investors.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of equity issuance and does not appear to contain significant negative or positive news.

Key Players & Entities

FAQ

What type of securities were issued by Mesoblast Limited?

The filing indicates a new issue of unquoted equity securities.

When was the announcement regarding the new securities made?

The announcement was made on December 17, 2025.

Where was the new issue announcement filed?

The announcement was filed with the Australian Securities Exchange.

What form was filed with the SEC?

Mesoblast Limited filed a Form 6-K.

Who is the Chief Executive Officer of Mesoblast Limited?

Silviu Itescu is the Chief Executive Officer and Executive Director.

Filing Stats: 224 words · 1 min read · ~1 pages · Grade level 18.8 · Accepted 2025-12-17 21:58:19

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly organized. Mesoblast Limited s Niva Sivakumar Niva Sivakumar Company Secretary Dated December 17, 2025 INDEX TO EXHIBITS Item 99.1 Appendix 3G of Mesoblast Ltd, dated December 17, 2025.

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing